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Background: In 2008, Africa accounted for 94% of the cholera cases reported worldwide. Although the World
Health Organization currently recommends the oral cholera vaccine in endemic areas for high-risk populations, its
use in Sub-Saharan Africa has been limited. Here, we provide the principal results of an evaluation of the cholera
surveillance system in the region of Maradi in Niger and an analysis of its data towards identifying high-risk areas
for cholera.
Results: We evaluated the cholera surveillance data using a standard CDC protocol, through interviews with heads
of the system, and a review of cholera data collected between 2006–2009. The surveillance system was found to be
sufficiently reliable to be able to utilize the data for the detection of high risk areas for cholera vaccination.
Temporal, geographic and socio-demographic analyses of cholera cases indicated that between 2006 and 2009, 433
cholera cases were reported in the Maradi region of Niger. Two deprived neighborhoods of the region’s capital city,
Bagalam and Yandaka, represented 1% of the regional population and 21% of the cholera cases, reaching a yearly
incidence rate of 3 per 1000 in 2006 and 2008, respectively.
Conclusions: The results of this evaluation suggest that the reporting sensitivity of the surveillance system is
sufficient, to appropriately classify the region as cholera endemic. Additionally, two overcrowded neighborhoods in
the regional capital met WHO criteria for consideration for cholera vaccination.Background
In 2008, Africa accounted for 94% of the cholera cases
reported to the World Health Organization (WHO).
Niger reported a small fraction of these cases, although
certain areas of the country face repeated epidemics
[1,2]. From 2000 to 2008, Niger reported cholera out-
breaks every year, mainly in the south of the country
and totaling close to 6000 cases [2]. The region of Mar-
adi has the highest population density in the country
and regularly reports cholera cases [2].
Two safe and effective oral cholera vaccines (Dukoral and
Shanchol) are now available and prequalified by WHO [3-
5], with some evidence of induced herd immunity [6,7]. To* Correspondence: j.guerra.sp@gmail.com
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reproduction in any medium, provided the oroptimize implementation in cholera-endemic areas, WHO
guidance recommends targeting oral cholera vaccination to
areas where culture-confirmed cholera has been detected in
at least 3 of the past 5 years; and incidence rates are at least
1/1000 population in any of these years or high-risk areas
or groups have been identified using information collected
from local public health officials [8]. Thus, epidemiological
knowledge of the burden of cholera in a specific area is
required before cholera vaccination is recommended. Al-
though WHO recommends the use of these vaccines in en-
demic areas, their use in Sub-Saharan Africa has been
limited [9].
National cholera surveillance systems are an affordable
way to collect epidemiological data before a cholera vac-
cination campaign is implemented. They must, however,
be evaluated [10], and if sound, surveillance data canLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cholera vaccination.
Here, we provide the results of an evaluation of the
surveillance system in the region of Maradi, Niger and
an analysis of its data towards identifying high-risk areas
that may be considered for potential cholera vaccination.
Methods
The region of Maradi is divided into 6 administrative dis-
tricts (Figure 1). Maradi city is the regional capital and the
second largest city in Niger. In collaboration with the re-
gional health authorities, we first evaluated the surveil-
lance system in the region following a standard protocol
developed by the Centers for Disease Control and Preven-
tion (Atlanta, Georgia, USA) [10]. Subsequently we ana-
lyzed this surveillance data, using WHO criteria to
identify high-risk areas to target oral cholera vaccination
in cholera endemic areas [8].
Briefly, the surveillance system evaluation covered the
simplicity, flexibility, reactivity, stability, representative-
ness and acceptability of the system as well as the quality
of data, the positive predictive value (PPV) and sensitiv-
ity. The evaluation, conducted in 2009 examines histor-
ical data since 2006 extracted from the Ministry of
Health (MoH) records. It included reviewing all reports
issued by the cholera surveillance system for the same
period, including case reports about the onset of epi-
demics and response to epidemics. The evaluation con-
sisted principally of detailed structured interviews with the
heads of the cholera surveillance system of the Maradi
region and with the heads of the 6 health facilities of the
city of Maradi.
Using MoH surveillance records extracted for 2006–
2009 and official population figures from the 2001 cen-
sus, we estimated the cumulative incidence rates of chol-
era by year, administrative district and by neighborhood
in Maradi city. For temporal analyses, we considered
consultation date of the cholera cases and for geographicFigure 1 Map of the region of Maradi.analyses the place of residence of cases. Available socio-
demographic data (age and sex) were used to describe
the cholera case population. For the identification of
cholera endemic areas we apply the WHO definition of
“the occurrence of fecal culture-confirmed cholera diar-
rhea in a population in at least 3 of the past 5 years” [8].
For the identification of high risk areas for potential
cholera vaccination we applied WHO criteria of areas
where 2 of the 3 following criteria are met: “(i) culture-
confirmed cholera has been detected in at least 3 of the
past 5 years; (ii) an incidence rate of cholera of at least
1/1000 population in any of these years has been
recorded; (iii) if population-based incidence rates are not
available, high-risk areas or groups have been identified
using information collected from local public health offi-
cials” [8]. R statistical software [11] was used to analyze
and present data collected from the surveillance system.
Participating heads of surveillance system orally con-
sented to be interviewed. Authorization was provided by
the Ministry of Health of Niger. No additional ethical com-
mittee approval was sought as we used routine surveillance
data provided by the MoH. No supplementary interven-
tions were conducted nor additional data collected for the
evaluation and analysis presented here. All data were an-
onymous and neither ethnic nor identifying information
was included.
Results
The following paragraphs present first, an overview of
the evaluation of the surveillance system, and second, an
epidemiologic description of the surveillance system data
to identify high risk-areas.
The surveillance system in Niger is based on WHO
reference guidelines [12], covering 7 potential epidemic
diseases, including cholera. No other surveillance system
for cholera exists nationally. The surveillance system
used the WHO standard case definition of cholera [12]:
– During an inter-epidemic period: any individual aged
5 years old or more who presented acute
dehydration or who died of acute watery diarrhea.
– During an epidemic period: any individual aged
5 years old or more who presented an acute watery
diarrhea with or without vomiting.
Both public and private health facilities are required to
report cholera cases and related deaths for persons over
5 years of age. Health facilities report disease data to their
sanitary districts (with one epidemiologist in charge). Each
district reports its data to the sanitary region, which in
turn reports to the MOH. During a cholera epidemic, es-
pecially at its onset, the heads of the surveillance system
at the district and regional level conduct field investiga-
tions in the affected areas in order to identify related
Guerra et al. BMC Research Notes 2012, 5:231 Page 3 of 7
http://www.biomedcentral.com/1756-0500/5/231cases. A case of cholera is confirmed when either Vibrio
cholerae O1 or O139 is isolated from the stool sample of a
suspected case. A cholera epidemic is declared as soon as
the first case of cholera is confirmed. Key attributes of the
cholera surveillance system for the evaluation of data are
presented in Tables 1 and 2. Complete results of the sur-
veillance system evaluation are available elsewhere [13].
The evaluation of the cholera surveillance system of the
Maradi region showed a good sensitivity of the system to
detect the cholera cases and good quality of reported in-
formation for persons 5 years of age and older.
Surveillance system data from 2006–2009 showed the
following epidemiologic indicators. Four hundred and
three cholera cases were reported in the region between
2006 and 2009, among which 18 (4.47%) deaths were
reported. No cases were reported in 2009. All epidemics
occurred during the rainy season (Figure 2). Compared
to the overall incidence rate of 0.05 per 1000 in the re-
gion for 2006 through 2009, the Maradi city incidence
rate was 0.27 per 1000 for the same period (Table 3 -
Figure 3). From 2006 to 2009, the mean age of cholera
cases was 25 years (Figure 4). During this period, 232
women and 170 men were reported as cholera cases (sex
ratio = 0.73, sex not available for 1 case). In the city, the
deprived neighborhoods of Bagalam and Yandaka, which
represent 1% of the regional population, reported 21% of
the cholera cases (n = 85). Incidence rates of 3 per 1000
were recorded in those neighborhoods in 2006 or 2008
(Table 4 - Figure 5).
The Maradi region met the WHO criteria for endemic














Sensitivity to detect a cholera epidemicwere identified as consistent high-risk areas for cholera
within the city of Maradi and met the criteria for cholera
vaccination according to the WHO recommendations.Discussion
We evaluated the cholera surveillance system of the re-
gion of Maradi and found the system sufficient to appro-
priately identify endemic and high risk areas for potential
cholera vaccination.
Overall, the evaluation of the surveillance system sug-
gests that the system is reasonably sensitive and that col-
lected data are representative of the distribution of cholera
cases in the region. Initial cholera cases were missed, but
most were subsequently identified and recorded. Further-
more, the systematic realization of stool cultures in sus-
pected cholera clusters and the high transmissibility of the
disease made it unlikely that an epidemic of cholera would
evade the surveillance system.
Few missing values were found. This may be due to
the regional centralization of the surveillance system
during cholera epidemics where data are checked daily
at the regional level. This increased communication and
feedback loop between local and regional levels helps to
improve data quality. Interviews with surveillance system
officers also asserted that seeking health care in case of
diarrhea during a cholera epidemic was common. Thus,
for people older than 5 years of age, and especially in
areas with health care facilities, non-reported severe
cholera cases should have been rare. The data issued
from Maradi’s surveillance system could be improved,with the data quality and sensitivity attributes of the
Results of the interviews and data collection
Very few missing values were found: 0/403 for the administrative
district, 3/403 for age, 1/403 for sex. Only data from 2006 to 2009
were available at the regional level.
Cholera cases were identified by the nurses in the healthcare facilities.
Difficulties were reported in the detection of the first cases of cholera.
Usually, the observation of a few cholera cases was necessary before
reporting of suspected cases of cholera started.
During an epidemic, all the suspected cholera cases were referred to
the cholera treatment centres (created at the onset of the epidemic),
where they were documented. Surveillance system leaders conducted
investigations to detect related cases and to inform the population
about cholera. Radio messages were broadcasted to inform the
population about cholera symptoms and encourage the reporting of
any suspected case to the heads of healthcare facilities. Four heads of
health structures reported that during epidemics, there was general
awareness of the gravity of cholera and the population was more
likely to seek care at healthcare facilities in case of acute diarrhea.
Each cluster of cholera cases was reported to the heads of the
surveillance system. All interviewees felt confident that each cluster
of cholera of cases was reported to the head of the surveillance system.
Table 2 Results of the interviews and data collection related with the positive predictive value and representativeness
attributes of the surveillance system





For the initial fifth through tenth suspected cholera cases, stool samples were collected to perform stool cultures. This
was done in the national laboratory in Niamey. Stool collection usually lacked for the first cholera cases. Tubes with Cary
Blair medium for the transport of the samples were not available from 2006 to 2009. For 26 cholera cultures results from
2006 to 2009 available at the time of the study, 13 were positive for Vibrio cholerea O1 ogawa (2 were positive fo




Each epidemic was confirmed by stool culture. If an epidemic was confirmed with five to ten stool samples, stoo
collection and testing ceased. Four heads of health structures reported that during an epidemic, the population was




cholera cases over time
Each week, each healthcare facility completed the notifiable diseases reports, which include the number of cholera cases
When a cholera case is suspected, the head of the healthcare facility promptly contacted the district epidemiologist
who in turn contacted the regional responsible of the surveillance system. During an epidemic, the count of cholera




In remote villages, the first cholera cases did not seek care at healthcare facilities. After a few cases had been noted, the





For each cholera case, specific forms were completed with accurate information including: age, sex, address, consultation
date, report date, date of symptom onset, vital status, and final diagnosis.Individuals aged less than 5 years are no
typically reported. Some cases in children under 5 were reported, however.
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confidence.
Several limitations should be kept in mind when inter-
preting the results of the surveillance system assessment.
First, the evaluation was retrospective and limited to a
four year observation period during which only two had
a large number of reported cases. Second, due to logis-
tical constraints, information about cholera surveillance
outside Maradi city was filled by regional heads only,
while within the city all the heads of health facilities
were also interviewed. In all cases, however, it was pos-
sible to contrast findings from interviews with surveil-
lance system reports. Third, as there was no alternative
surveillance system for comparison, the evaluation was
based solely on a retrospective review of MoH records,





twas assessed qualitatively. Fourth, initial clinically sus-
pected cases were laboratory confirmed, but as testing
ceased after the epidemic was confirmed, a specific study
would be necessary to fully evaluate the system’s PPV.
Lastly, the surveillance system was designed to capture
cases 5 years of age and older. While this follows WHO
surveillance recommendations, it does necessarily result
in an underestimation of cases in this age-group.
As an estimated 40% of the population resides more
than 5 km from a health facility [14], under-reporting
from these more distal areas could lead to inaccurate epi-
demiological estimations. In fact, sensitivity at the onset of
epidemics appears to have been lower in rural areas, espe-
cially in remote villages and health centres. Due to cho-
lera’s severity and high transmissibility, however, and
supported by the results of our evaluation, it appears that















Aguié 0 0.00 18 0.07 0 0.00 18 0.02
Dakoro 0 0.00 0 0.00 0 0.00 0 0.00
Guidan Roumdji 6 0.02 0 0.00 4 0.01 10 0.01
Madarounfa 130 0.46 0 0.00 1 0.00 131 0.11
City of Maradi 73 0.50 0 0.00 86 0.58 159 0.27
Mayahi 0 0.00 0 0.00 30 0.08 30 0.02
Tessaoua 0 0.00 0 0.00 55 0.16 55 0.04
Total region 209 0.09 18 0.01 176 0.08 403 0.05
*The city of Maradi is listed separately although it is included in the administrative district of Madarounfa.
†No cholera cases were reported in 2009.
{Incidence rates per 1000 inhabitants.
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by health authorities. Conversely, an overestimation of
cholera cases may have occurred, particularly in urban
areas due to over-attribution of non-cholera diarrheas.
The clustering of cholera cases in Maradi, in addition to
most neighborhoods reporting no cases suggests that
over-reporting did not play a major role either.
An additional limitation applies to the calculation of
incidence rates. Population data from the 2001 census
would likely underestimate the population figures during
the period 2006–2009, resulting in an overestimation of
incidence rates in the study period. Cholera caseload
could, however, as noted in Bangladesh be several-fold
higher than the figure presenting at hospitals [15]. Fur-
thermore, the system does not routinely report cases
under 5 years of age, which in some Asian and African
settings present with higher attack rates and are more
prone to be hospitalized during cholera epidemics
[16,17]. Consequently it is more likely that cholera inci-
dence rates are higher than presented here, despite the
population underestimation.Figure 3 Distribution of cholera cases in the region of Maradi over 3Our evaluation suggests that the cholera surveillance
system in place during the reviewed period is reasonably
sensitive and could be used for detection of areas at risk
for cholera epidemics. WHO criteria to implement a vac-
cination campaign [8] were met in the neighborhoods of
Bagalam and Yandaka in the city of Maradi. The city of
Maradi is the major transport trade and agricultural hub
of the region. These neighborhoods are also among the
poorest of the city, over-crowded and are susceptible to
flooding. These factors may explain why the city took a
major part in the spread of cholera epidemics, particularly
in the overcrowded, poor sanitation neighborhoods of
Bagalam and Yandaka. Following this evaluation and iden-
tification, these two neighborhoods are being considered
for a cholera vaccination campaign. Of the two currently
available prequalified oral cholera vaccines, Shanchol does
not require a buffer or water for administration, is less ex-
pensive and potentially promising for use in contexts with
limited sanitation infrastructures [18]. In overcrowded,
poor sanitation neighborhoods in the city of Beira, Mo-
zambique, Jeuland et al estimated that a vaccinationyears.
Figure 4 Age distribution of the cholera cases reported in the region of Maradi from 2006 to 2009 and age distribution of the
inhabitants of the region of Maradi in 2001.
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would be very cost-effective [19], despite the logistical
difficulties to its implementation. The implementation of a
similar long-term oral cholera vaccination campaign in the
identified neighborhoods of Bagalam and Yandaka may
present similar results, until associated water and sanitation
infrastructure are improved.Table 4 Cholera cases in the city of Maradi reported to the na
neighborhood
Neighborhoods of the city of Maradi 2006
Cholera cases Incidence†
Ali Dan Sofo 0 0.00
Bagalam 40 3.08
Bourja 1 0.09
Bouzou Dan Zamba 1 0.10




Mazadou Djika 1 0.27
Nouveau carré{ 0
Sabon Gari 5 0.24
Soura Bildi 6 0.36
Yandaka 2 0.25
Zaria 5 0.19
Neighborhood not documented 7
*No cholera cases were reported in 2007 and 2009.
†Incidence rates per 1000 inhabitants.
{Population figures not available.Conclusion
By evaluating the surveillance system and subsequently
the surveillance data, the Maradi region could be consid-
ered endemic for cholera. Two high risk neighborhoods
in the regional capital were identified as candidates for
preventive cholera vaccination. This case study shows
that evaluation of surveillance systems and the use of itstional surveillance system between 2006 and 2009 by
2008 Total 2006-2009*
Cholera cases Incidence† Cholera cases Incidence†
2 0.25 2 0.06
19 1.46 59 1.14
0 0.00 1 0.02
0 0.00 1 0.03
1 0.21 2 0.11
2 3
3 0.43 5 0.18
6 0.37 7 0.11
0 0.00 1 0.07
5 5
4 0.19 9 0.11
6 0.36 12 0.18
24 2.99 26 0.81
0 0.00 5 0.05
14 21
Figure 5 Distribution of cholera cases by neighborhood in the city of Maradi.
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identification of high-risk areas for cholera in low- and
middle-income settings before considering cholera vac-
cination campaigns.
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